Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients

dc.date.accessioned	2023-03-06T07:32:42Z
dc.date.available	2023-03-06T07:32:42Z
dc.date.issued	2022
dc.identifier.citation	J Med Virol. 2022 Jul;94(7):3176-3183. doi: 10.1002/jmv.27714. Epub 2022 Mar 22.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100416
dc.relation.isversionof	10.1002/jmv.27714
dc.relation.isversionof	10.1002/jmv.27714
dc.title	Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients
dc.relation.journal	J Med Virol
dc.identifier.doi	10.1002/jmv.27714
dc.contributor.author	Dheir H
dc.contributor.author	Dheir H
dc.contributor.author	Tocoglu A
dc.contributor.author	Toptan H
dc.contributor.author	Pinar M
dc.contributor.author	Demirci T
dc.contributor.author	Koroglu M
dc.contributor.author	Yaylaci S